Yanagihashi, Masaru
Hirayama, Takehisa
Shibukawa, Mari
Nagasawa, Junpei
Fujita, Koji
Izumi, Yuishin
Morita, Mitsuya
Bokuda, Kota
Takahashi, Kazushi
Kanai, Kazuaki
Atsuta, Naoki
Iguchi, Yohei
Katsuno, Masahisa
Murakami, Yoshitaka
Mitsumoto, Hiroshi
Kano, Osamu
Article History
Received: 20 April 2024
Accepted: 14 June 2024
First Online: 13 August 2024
Declarations
:
: The study protocol was approved by the Ethics Committee of Toho University Faculty of Medicine, Tokyo, Japan (A21013, M20282), and other participating institutions (4058, rinfu 21 − 008, TS R03-017, ippan2021-318, 2021 − 0101).
: These data were presented at the 64th Annual Meeting of Japanese Society of Neurology, Chiba, Japan, the 41st Annual Meeting of Japanese Society of Neurotherapy, Tokyo, Japan, Neurodegenerative Disease Workshop in 2020, 2023, Tokyo, Japan.
: Not applicable.
: The authors declare no competing interests.